EDITORIAL: "NAESSENS, C'EST L'AVENIR"

 

From The Cancer Chronicles #24-25
© Dec. 1994 by Ralph W. Moss, Ph.D.

 

"Then felt I like some watcher of the skies
When a new planet swims into his ken..."—Keats


Hardly a week goes by that I am not approached by advocates of some new cancer treatment. There are 102 methods in my book Cancer Therapy, and future editions will hold more. One can go batty sorting out the claims.

This spring I decided I needed to go deeper into a few such methods. Just then, a long-time friend suffered a relapse of her breast cancer. IAT therapy, which for years had held her cancer at bay, was no longer working. But when she added 714X, her breast tumor vanished. That made me sit up and take notice.

In August I drove north to interview Mr. Gaston Naessens, the product's developer. I have been back twice since then. The result is the first-ever double issue of the Chronicles.

I always try to be a dispassionate observer of all proposed cancer treatments. But I want to share with you my feelings about this story. I understand the sentiments expressed by Dietmar Schildwaechter, MD, who described his first encounter with Naessens. After a long career, by 1990 Schildwaechter was weary of the medical wars and was on the verge of retiring.

"Meeting Naessens changed my life," he told me with great conviction "and gave me a new interest in medicine."

I hope 714X and all of Naessens's ideas will soon be tested. If he is wrong, then at least he is spectacularly wrong, and in fact his errors may prove more fruitful than some other people's small truths. But if he is right (and I believe he is), then he is a really great genius, and like his countryman, Pasteur, one of the towering figures in the history of medicine. I keep thinking about the placards demonstrators carried at his 1989 trial.

"Naessens," the demonstrators proclaimed, "C'est l'avenir." Naessens is the future.


Ralph W. Moss, Ph.D. is the author of many books and documentaries on cancer-related topics. He has been an advisor on alternative cancer treatments to the National Institutes of Health, Columbia University, and the University of Texas. He researches and writes The Moss Reports on cancer. For information, please contact coordinator Anne Beattie @ 144 St. John's Place, Brooklyn, NY 11217; Phone 718-636-4433; Fax 718-636-0186.


Return Home